Medication Adherence: WHO Cares?

Brown, Marie T.; Bussell, Jennifer K.
April 2011
Mayo Clinic Proceedings;Apr2011, Vol. 86 Issue 4, p304
Academic Journal
The treatment of chronic illnesses commonly includes the longterm use of pharmacotherapy. Although these medications are effective in combating disease, their full benefits are often not realized because approximately 50% of patients do not take their medications as prescribed. Factors contributing to poor medication adherence are myriad and include those that are related to patients (eg, suboptimal health literacy and lack of involvement in the treatment decision-making process), those that are related to physicians (eg, prescription of complex drug regimens, communication barriers, ineffective communication of information about adverse effects, and provision of care by multiple physicians), and those that are related to health care systems (eg, office visit time limitations, limited access to care, and lack of health information technology). Because barriers to medication adherence are complex and varied, solutions to improve adherence must be multifactorial. To assess general aspects of medication adherence using cardiovascular disease as an example, a MEDLINE-based literature search (January 1, 1990, through March 31, 2010) was conducted using the following search terms: cardiovascular disease, health literacy, medication adherence, and pharmacotherapy. Manual sorting of the 405 retrieved articles to exclude those that did not address cardiovascular disease, medication adherence, or health literacy in the abstract yielded 127 articles for review. Additional references were obtained from citations within the retrieved articles. This review surveys the findings of the identified articles and presents various strategies and resources for improving medication adherence.


Related Articles

  • Factors Influencing the Prescription of Cardiovascular Preventive Therapies in Patients with Peripheral Arterial Disease. Montminy, Myriam L.; Gauvin, Valerie; Turcotte, Stephane; Milot, Alain; Douville, Yvan; Bairati, Isabelle // PLoS ONE;2/5/2016, Vol. 11 Issue 2, p1 

    Background: Guidelines recommend that patients with peripheral arterial disease should be medically treated to reduce the occurrence of serious cardiovascular events. Despite these recommendations, studies conducted in the early 2000s reported that medical therapies for secondary cardiovascular...

  • Assessing medication adherence: options to consider. Lehmann, Audrey; Aslani, Parisa; Ahmed, Rana; Celio, Jennifer; Gauchet, Aurelie; Bedouch, Pierrick; Bugnon, Olivier; Allenet, BenoĆ®t; Schneider, Marie // International Journal of Clinical Pharmacy;Feb2014, Vol. 36 Issue 1, p55 

    Background Adherence to chronic therapy is a key determinant of patient health outcomes in chronic disease. However, only about 50 % of patients adhere to chronic therapy. One of the challenges in promoting adherence is having an accurate understanding of adherence rates and the factors that...

  • Combination Pill for Cardiovascular Disease. Carey, Michelle // JAMA: Journal of the American Medical Association;1/1/2014, Vol. 311 Issue 1, p93 

    A letter to the editor is presented in response to the article "Effects of a Fixed-Dose Combinations Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD: The UMPIRE Randomized Clinical Trial" by S. Thom and colleagues in the 2013 issue of the "Journal of the American...

  • Combination Pill for Cardiovascular Disease. Thom, Simon; Rodgers, Anthony // JAMA: Journal of the American Medical Association;1/1/2014, Vol. 311 Issue 1, p93 

    A response from the authors of the article "Effects of a Fixed-Dose Combinations Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD: The UMPIRE Randomized Clinical Trial" in the 2013 issue of the "Journal of the American Medical Association" is presented.

  • The possibility of unmeasured confounding variables in observational studies: a forgotten fact? Byrd, James Brian; Ho, P. Michael // Heart;Nov2011, Vol. 97 Issue 22, p1815 

    An introduction is presented in which the editor discusses an article within the issue on treatment adherence and adverse outcomes of anti-hypertensive medications in treatment of cardiovascular disorders. INSET: Heart impact factor.

  • Non-adherent patients? Check your communication skills.  // Case Management Advisor;Jul2013, Vol. 24 Issue 7, p73 

    The article discusses the significant role of case managers when patients are not following their treatment plan. It notes that BK and Associates owner BK Kizziar has suggested the need for case managers to assess what they can do to help the patients. It also tackles the need for the, to make...

  • Adherence to medication for chronic disorders during pregnancy: results from a multinational study. Lupattelli, Angela; Spigset, Olav; Nordeng, Hedvig // International Journal of Clinical Pharmacy;Feb2014, Vol. 36 Issue 1, p145 

    Background For a variety of chronic disorders, low medication adherence during pregnancy may jeopardize maternal as well as foetal health. Little is known about how closely pregnant women follow their chronic pharmacotherapy regimens. Objective To explore the level of adherence to medication for...

  • Initiation of antidepressant therapy: do patients follow the GP's prescription? Van Geffen, Erica C. G.; Gardarsdottir, Helga; Van Hulten, Rolf; Van Dijk, Liset; Egberts, Antoine C. G.; Heerdink, Eibert R. // British Journal of General Practice;Feb2009, Vol. 59 Issue 559, p81 

    Background The question whether patients actually start drug taking after having received a first antidepressant prescription is often overlooked. Aim To determine the incidence of patients who do not fill or fill only a single antidepressant prescription at the pharmacy, and to identify...

  • Bromide as a marker to measure adherence to drug therapy. Braam, Richard L.; van Uum, Stan H. M.; Russel, Frans G. M.; Swinkels, Dorine W.; Thien, Theo // European Journal of Clinical Pharmacology;Apr2006, Vol. 62 Issue 4, p285 

    Several methods have been described to measure adherence to prescribed drug therapy. However, most of these have been shown to be inaccurate. Bromide is an anion that is readily absorbed in the gut and has an elimination half-life of about 12 days. In the present study, we investigated the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics